NEWTON, Mass.--(BUSINESS WIRE)--Clinical Data, Inc. (NASDAQ:CLDA), a leader in the development of targeted therapeutics and predictive tests from its growing portfolio of proprietary genetic biomarkers, announced today that its Chief Medical Officer, Carol Reed, MD, will participate at the Symposium on “Toxicogenomics and Personalized Medicine: Minimizing Toxicity While Optimizing Treatment” on Monday, February 4, 2008 at The New York Academy of Sciences, located at 7 World Trade Center, 250 Greenwich St. at Barclay St., 40th floor. The Symposium will take place from 1:00 pm to 5:30 pm.
